Giuseppe Floresta Selected Research

Giuseppe Floresta Research Topics

Disease

15	Neoplasms (Cancer) 10/2023 - 10/2017
4	Inflammation (Inflammations) 10/2022 - 09/2017
2	Carcinoma (Carcinomatosis) 08/2022 - 01/2018
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2022 - 10/2018
2	Type 2 Diabetes Mellitus (MODY) 12/2021 - 01/2019
1	Obesity 10/2023
1	Weight Loss (Weight Reduction) 10/2023
1	Sleep Initiation and Maintenance Disorders (Insomnia) 10/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 08/2022
1	Atopic Dermatitis (Atopic Eczema) 08/2022
1	Globoid Cell Leukodystrophy (Krabbe Disease) 08/2022
1	Psoriatic Arthritis 08/2022
1	Botulism 12/2020
1	Pathologic Processes 10/2020
1	Breast Neoplasms (Breast Cancer) 03/2020
1	Dystonic Disorders (Writer's Cramp) 01/2020
1	Migraine Disorders (Migraine) 01/2020
1	Dehydration (Water Stress) 01/2020
1	Hyperglycemia 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 10/2018
1	Melanoma (Melanoma, Malignant) 05/2018
1	Squamous Cell Carcinoma of Head and Neck 01/2018
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 11/2017
1	Atherosclerosis 09/2017

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 10/2022 - 10/2018
4	Heme Oxygenase-1IBA 01/2021 - 10/2018
3	Fatty Acid-Binding ProteinsIBA 10/2023 - 10/2022
3	Fatty Acids (Saturated Fatty Acids)IBA 10/2022 - 09/2017
2	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2023 - 04/2021
2	Tyrosine Kinase InhibitorsIBA 05/2022 - 10/2018
2	LigandsIBA 01/2022 - 10/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2020 - 05/2018
2	EnzymesIBA 04/2019 - 10/2018
1	semaglutideIBA 10/2023
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 10/2023
1	IronIBA 07/2023
1	IntegrinsIBA 08/2022
1	ibudilastIBA 08/2022
1	RoflumilastIBA 08/2022
1	apremilastIBA 08/2022
1	crisaboroleIBA 08/2022
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 08/2022
1	Phosphodiesterase 4 InhibitorsIBA 08/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2022
1	Acarbose FDA LinkGeneric 12/2021
1	benzothiazoleIBA 12/2021
1	AmidesIBA 12/2021
1	Heme (Haem)IBA 01/2021
1	incobotulinumtoxinA FDA Link 12/2020
1	Type A Botulinum Toxins (Botox)FDA Link 12/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2020
1	PyrrolesIBA 05/2020
1	polypropylene glycol (poly(propylene oxide))IBA 05/2020
1	Carbon Nanotubes (Carbon Nanotube)IBA 05/2020
1	Hormones (Hormone)IBA 03/2020
1	cucurbit(7)urilIBA 01/2020
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019
1	GlucosidasesIBA 01/2019
1	PolyphenolsIBA 01/2019
1	Rosmarinic AcidIBA 01/2019
1	AntioxidantsIBA 01/2019
1	Imatinib Mesylate (Gleevec)FDA Link 10/2018
1	Phosphotransferases (Kinase)IBA 10/2018
1	2- (2- methoxybenzyl)- 3- (1,10- phenanthrolin- 2- yl)isoxazolidin- 5- yl)methanolIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Intercalating AgentsIBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Histone Deacetylase InhibitorsIBA 11/2017
1	romidepsin (FK228)FDA Link 11/2017
1	Vorinostat FDA Link 11/2017
1	Haloperidol (Haldol)FDA LinkGeneric 10/2017
1	ProdrugsIBA 10/2017
1	Urea (Carbamide)FDA LinkGeneric 09/2017
1	quinolineIBA 09/2017
1	Niacin (Nicotinic Acid)FDA LinkGeneric 09/2017
1	Heterocyclic Compounds (Compounds, Heterocyclic)IBA 09/2017
1	pyridineIBA 09/2017
1	QuinoxalinesIBA 09/2017

Therapy/Procedure

1	Therapeutics 10/2018